atrial fibrillation and stroke prevention - Continuing Medical ...
atrial fibrillation and stroke prevention - Continuing Medical ...
atrial fibrillation and stroke prevention - Continuing Medical ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Essentials in Primary Care Conference<br />
Wednesday, July 31, 2013<br />
Question 1<br />
What are the major advantages of<br />
Dabigatran over Warfarin?<br />
1. It’s low price<br />
2. It is easier to reverse in the event of serious<br />
bleeding<br />
3. Compared with warfarin, it is associated with a<br />
lower risk of <strong>stroke</strong> in those with non-valvular<br />
<strong>atrial</strong> <strong>fibrillation</strong><br />
4. The dose of dabigatran does not need to be<br />
adjusted for impaired renal function<br />
5. It is easy to check the adequacy of its<br />
antithrombotic effect<br />
Question 2<br />
What is the annual risk of <strong>stroke</strong> in a 72 year<br />
old man with hypertension <strong>and</strong> diabetes using<br />
the CHADS 2 scoring system<br />
1) Annual <strong>stroke</strong> risk is about 1-3%<br />
2) Annual <strong>stroke</strong> risk is about 3-5%<br />
3) Annual <strong>stroke</strong> risk is about 8-11%<br />
4) Annual <strong>stroke</strong> risk is about 13-18%<br />
5) I am not sure what the CHADS2 scoring<br />
system is?<br />
Jan Basile, MD<br />
Atrial Fibrillation & Stroke Prevention
Change language